273 related articles for article (PubMed ID: 22959497)
1. Effect of low- and high-glycemic load on circulating incretins in a randomized clinical trial.
Runchey SS; Valsta LM; Schwarz Y; Wang C; Song X; Lampe JW; Neuhouser ML
Metabolism; 2013 Feb; 62(2):188-95. PubMed ID: 22959497
[TBL] [Abstract][Full Text] [Related]
2. A high-protein breakfast induces greater insulin and glucose-dependent insulinotropic peptide responses to a subsequent lunch meal in individuals with type 2 diabetes.
Park YM; Heden TD; Liu Y; Nyhoff LM; Thyfault JP; Leidy HJ; Kanaley JA
J Nutr; 2015 Mar; 145(3):452-8. PubMed ID: 25733459
[TBL] [Abstract][Full Text] [Related]
3. Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study.
Runchey SS; Pollak MN; Valsta LM; Coronado GD; Schwarz Y; Breymeyer KL; Wang C; Wang CY; Lampe JW; Neuhouser ML
Eur J Clin Nutr; 2012 Oct; 66(10):1146-52. PubMed ID: 22892437
[TBL] [Abstract][Full Text] [Related]
4. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM
Am J Clin Nutr; 2009 Jan; 89(1):106-113. PubMed ID: 19056578
[TBL] [Abstract][Full Text] [Related]
5. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
[TBL] [Abstract][Full Text] [Related]
6. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.
Ma J; Pilichiewicz AN; Feinle-Bisset C; Wishart JM; Jones KL; Horowitz M; Rayner CK
Diabet Med; 2012 May; 29(5):604-8. PubMed ID: 22004512
[TBL] [Abstract][Full Text] [Related]
7. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
[TBL] [Abstract][Full Text] [Related]
8. Incretin secretion in humans is under the influence of cannabinoid receptors.
Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
[TBL] [Abstract][Full Text] [Related]
9. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
10. The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.
Smith K; Taylor GS; Allerton DM; Brunsgaard LH; Bowden Davies KA; Stevenson EJ; West DJ
Front Endocrinol (Lausanne); 2021; 12():696977. PubMed ID: 34220720
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
[TBL] [Abstract][Full Text] [Related]
12. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
[TBL] [Abstract][Full Text] [Related]
13. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
14. Effect of increased physical activity on fructose-induced glycemic response in healthy individuals.
Bidwell AJ; Fairchild TJ; Wang L; Keslacy S; Kanaley JA
Eur J Clin Nutr; 2014 Sep; 68(9):1048-54. PubMed ID: 24848627
[TBL] [Abstract][Full Text] [Related]
15. Prior exercise and postprandial incretin responses in lean and obese individuals.
Heden TD; Liu Y; Kearney ML; Park Y; Dellsperger KC; Thomas TR; Kanaley JA
Med Sci Sports Exerc; 2013 Oct; 45(10):1897-905. PubMed ID: 23559122
[TBL] [Abstract][Full Text] [Related]
16. Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans.
Wu T; Zhao BR; Bound MJ; Checklin HL; Bellon M; Little TJ; Young RL; Jones KL; Horowitz M; Rayner CK
Am J Clin Nutr; 2012 Jan; 95(1):78-83. PubMed ID: 22158727
[TBL] [Abstract][Full Text] [Related]
17. Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants.
Bannon CA; Meek CL; Reimann F; Gribble FM
Peptides; 2024 Jun; 176():171186. PubMed ID: 38490484
[TBL] [Abstract][Full Text] [Related]
18. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
19. Postprandial plasma incretin hormones in exercise-trained versus untrained subjects.
Weiss EP; Royer NK; Fisher JS; Holloszy JO; Fontana L
Med Sci Sports Exerc; 2014 Jun; 46(6):1098-103. PubMed ID: 24576859
[TBL] [Abstract][Full Text] [Related]
20. Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
McMillan CJ; Zapata RC; Chelikani PK; Snead EC; Cosford K
Domest Anim Endocrinol; 2016 Jan; 54():85-94. PubMed ID: 26609567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
